What's Happening?
Calyxo, Inc., a medical device company based in Pleasanton, California, has successfully closed a $40 million Series F financing round. The funding was led by Ally Bridge Group and Janus Henderson Investors, with additional support from Questa Capital,
Avidity Partners, and CRG. This financial boost comes as Calyxo's CVAC System, an aspiration-based stone removal technology, has treated over 40,000 patients. The CVAC System is designed to improve kidney stone treatment by enabling more complete stone clearance, which is believed to lead to better patient outcomes. The funds will be used to expand Calyxo's commercial infrastructure, advance clinical and health economic evidence generation, and support ongoing innovation in kidney stone care.
Why It's Important?
The financing marks a significant milestone for Calyxo, highlighting the growing recognition of its CVAC System in the medical community. The system's ability to achieve more complete stone clearance could potentially reduce healthcare costs and improve patient outcomes, addressing a significant need in kidney stone treatment. With approximately 10% of the U.S. population expected to experience kidney stones in their lifetime, the demand for effective treatment solutions is high. The investment will enable Calyxo to further establish its technology as a standard of care, potentially transforming the landscape of kidney stone treatment and reducing the economic burden associated with this condition.
What's Next?
Calyxo plans to use the new funding to accelerate the expansion of its commercial operations and continue its research into the long-term outcomes of its CVAC System. The company aims to solidify its position in the market by providing robust clinical evidence supporting the efficacy and cost-effectiveness of its technology. As the company advances its technology and expands its evidence base, it is likely to attract more attention from healthcare providers and investors, potentially leading to further growth and innovation in the field of kidney stone treatment.
